CHC Healthcare Group 

TWD32.2
2
-TWD0.55-1.68% Wednesday 05:30

Statistics

Day High
32.75
Day Low
32
52W High
51.7
52W Low
30.1
Volume
1,415,958
Avg. Volume
-
Mkt Cap
6.29B
P/E Ratio
32.75
Dividend Yield
4.21%
Dividend
1.36

Upcoming

Dividends

4.21%Dividend Yield
Jul 25
TWD1.36
Aug 24
TWD2
Aug 23
TWD1.97
Aug 22
TWD2.01
Aug 21
TWD2.01
10Y Growth
-3.82%
5Y Growth
-7.53%
3Y Growth
-11.67%
1Y Growth
N/A

Earnings

30AprExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
0.05
0.22
0.39
0.56
Expected EPS
0.305676735722
Actual EPS
N/A

Financials

4.68%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
7.2BRevenue
336.77MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 4164.TW. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Cx Technology
2415.TW
Mkt Cap2.43B
United Integrated Services specializes in providing similar healthcare services and solutions in Taiwan, directly competing in the same market as CHC Healthcare.
Excelsior Medical
4104.TW
Mkt Cap14.81B
Standard Chem & Pharm Co., Ltd. operates in the pharmaceutical sector in Taiwan, competing with CHC Healthcare in the healthcare solutions space.
Sinphar Pharmaceutical
1734.TW
Mkt Cap6.11B
Sinphar Pharmaceutical focuses on the manufacture and sale of pharmaceutical products, competing with CHC Healthcare in the healthcare and medical services industry.
ScinoPharm Taiwan
1789.TW
Mkt Cap16.61B
Golden Biotechnology Corp. engages in research and development in biotechnology, offering competitive healthcare solutions in the same regional market.
Wellell
4106.TW
Mkt Cap2.27B
Sun Ten Pharmaceutical Co., Ltd. competes by providing traditional Chinese medicine and herbal products, targeting similar healthcare sectors as CHC Healthcare.
PharmaEssentia
6446.TW
Mkt Cap240.51B
Taiwan Advance Bio-Pharm Inc. competes in the biopharmaceutical field, developing products that can overlap with CHC Healthcare's market.
Bionime
4737.TW
Mkt Cap5.16B
PharmaEngine, Inc. focuses on the development of new drugs, potentially competing in the innovative healthcare solutions sector alongside CHC Healthcare.
Panion & Bf Biotech
1760.TW
Mkt Cap5.57B
Taiwan Biotech Co., Ltd. is a major player in the biotechnology and pharmaceutical industry, offering products and services that compete with CHC Healthcare's offerings.

About

CHC Healthcare Group, together with its subsidiaries, trades in medical equipment, pharmaceutical products, and health food in Taiwan, China, and internationally. The company is also involved in the leasing, installing, servicing, and repairing of medical instruments for use in various specialties, such as radiation oncology, medical imaging, neurology, surgery, ophthalmology, robot rehabilitation, dentistry, and smart health care. In addition, it engages in the irradiation business; sale of daily necessities, beauty products, and health supplements; elderly residence, long-term care, and senior services; leasing of veterinary medical instruments; department setup, business management consultation, and educational training and staff development for healthcare personnel; technical support and maintenance; radiation sterilization business; and online and physical store pharmacy chain activities. The company was formerly known as Cheng Yeh Holdings Co., Ltd. and changed its name to CHC Healthcare Group in 2012. CHC Healthcare Group was incorporated in 2009 and is headquartered in Taipei, Taiwan.
Show more...
CEO
Mr. Tien-Ying Lee
Country
Taiwan
ISIN
TW0004164009

Listings

0 Comments

Share your thoughts

FAQ

What is CHC Healthcare Group stock price today?
The current price of 4164.TW is TWD32.2 TWD — it has decreased by -1.68% in the past 24 hours. Watch CHC Healthcare Group stock price performance more closely on the chart.
What is CHC Healthcare Group stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange CHC Healthcare Group stocks are traded under the ticker 4164.TW.
Is CHC Healthcare Group stock price growing?
4164.TW stock has risen by +2.22% compared to the previous week, the month change is a +4.55% rise, over the last year CHC Healthcare Group has showed a -24.59% decrease.
What is CHC Healthcare Group market cap?
Today CHC Healthcare Group has the market capitalization of 6.29B
When is the next CHC Healthcare Group earnings date?
CHC Healthcare Group is going to release the next earnings report on April 30, 2026.
What is CHC Healthcare Group revenue for the last year?
CHC Healthcare Group revenue for the last year amounts to 7.2B TWD.
What is CHC Healthcare Group net income for the last year?
4164.TW net income for the last year is 336.77M TWD.
Does CHC Healthcare Group pay dividends?
Yes, 4164.TW dividends are paid annual. The last dividend per share was 1.36 TWD. As of today, Dividend Yield (FWD)% is 4.21%.
In which sector is CHC Healthcare Group located?
CHC Healthcare Group operates in the Health & Wellness sector.
When did CHC Healthcare Group complete a stock split?
CHC Healthcare Group has not had any recent stock splits.
Where is CHC Healthcare Group headquartered?
CHC Healthcare Group is headquartered in Taipei, Taiwan.